Research
Hormonal
Time-restricted eating combined with calorie restriction does not provide significant additional benefits for blood pressure, glucose profile, or lipid profile compared to calorie restriction alone.
Do not expect time-restricted eating to fix your blood pressure, blood sugar, or cholesterol if you are just counting calories. The benefits for these markers are not significantly better than just counting calories alone. Focus on the weight loss aspect of TRE.
ModerateRefutesLOW confidence
However, compared with CR alone, TRE plus CR exhibited no significant benefit on the blood pressure, glucose profile, and lipid profile.
Why this rating
Based on 8 RCTs; GRADE for these outcomes was 'low' or 'very low'.
Source
Time-restricted eating with calorie restriction on weight loss and cardiometabolic risk: a systematic review and meta-analysis
Jing-Chao Sun et al. · European Journal of Clinical Nutrition · 2023
DOI 10.1038/s41430-023-01311-w
Meta-analysis · 8 studiesCited 44×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Combining time-restricted eating (TRE) with calorie restriction (CR) significantly reduces body weight, fat mass, and waist circumference compared to calorie restriction alone in overweight or obese adults.Moderate
- Early Time-Restricted Eating (eTRE) combined with calorie restriction is more effective for weight loss and fat mass reduction than delayed TRE (dTRE) or broader TRE windows.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →